Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A van Acker

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Toxicology Letters|January 15, 1997
Acute exposure to ozone does not influence neuroreceptor density and sensitivity in guinea pig lungH J van Hoof, F A van Acker, H P Voss, et al.
FEBS Letters|May 17, 2000
Flavonoids can replace alpha-tocopherol as an antioxidantF A van Acker, O Schouten, G R Haenen, et al.
Chemical Research in Toxicology|January 1, 1997
A refined substrate model for human cytochrome P450 2D6M J de Groot, G J Bijloo, B J Martens, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|March 22, 2001
Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groupsC G Heijnen, G R Haenen, F A van Acker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Frederine, a new and promising protector against doxorubicin-induced cardiotoxicityF A van Acker, E Boven, K Kramer, et al.
Anticancer Research|February 24, 2001
In vitro screening of antitumour agents for cardiotoxicity by means of isolated mouse left atriaF A van Acker, S A van Acker, G R Haenen, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 1, 1997
Extension of a predictive substrate model for human cytochrome P4502D6M J de Groot, G J Bijloo, F A van Acker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
7-monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per weekF A van Acker, S A van Acker, K Kramer, et al.
Journal of Medicinal Chemistry|October 6, 2000
Synthesis of novel 3,7-substituted-2-(3',4'-dihydroxyphenyl)flavones with improved antioxidant activityF A van Acker, J A Hageman, G R Haenen, et al.
Free Radical Biology & Medicine|June 27, 2001
New synthetic flavonoids as potent protectors against doxorubicin-induced cardiotoxicityF A van Acker, J W Hulshof, G R Haenen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Toxicology Letters|January 15, 1997
Acute exposure to ozone does not influence neuroreceptor density and sensitivity in guinea pig lungH J van Hoof, F A van Acker, H P Voss, et al.
FEBS Letters|May 17, 2000
Flavonoids can replace alpha-tocopherol as an antioxidantF A van Acker, O Schouten, G R Haenen, et al.
Chemical Research in Toxicology|January 1, 1997
A refined substrate model for human cytochrome P450 2D6M J de Groot, G J Bijloo, B J Martens, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|March 22, 2001
Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groupsC G Heijnen, G R Haenen, F A van Acker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Frederine, a new and promising protector against doxorubicin-induced cardiotoxicityF A van Acker, E Boven, K Kramer, et al.
Anticancer Research|February 24, 2001
In vitro screening of antitumour agents for cardiotoxicity by means of isolated mouse left atriaF A van Acker, S A van Acker, G R Haenen, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 1, 1997
Extension of a predictive substrate model for human cytochrome P4502D6M J de Groot, G J Bijloo, F A van Acker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
7-monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per weekF A van Acker, S A van Acker, K Kramer, et al.
Journal of Medicinal Chemistry|October 6, 2000
Synthesis of novel 3,7-substituted-2-(3',4'-dihydroxyphenyl)flavones with improved antioxidant activityF A van Acker, J A Hageman, G R Haenen, et al.
Free Radical Biology & Medicine|June 27, 2001
New synthetic flavonoids as potent protectors against doxorubicin-induced cardiotoxicityF A van Acker, J W Hulshof, G R Haenen, et al.
Pageof 2